MAPT and Alzheimer disease: They found that knockdown of FRMD4A, whose gene polymorphisms are a risk factor for AD [163], reduced the secretion of tau dimer from transfected HEK293T cells into the culture medium, whereas overexpression of FRMD4A enhanced the tau secretion in a dose-dependent manner.